http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 23 Jan 2026 17:39:10 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html <p>Jack Nathan Medical Corp. (TSXV: JNH) announced Mike Marchelletta stepped down as chief executive officer to lead a potential investor syndicate evaluating strategic transactions involving the company.</p> <p>Michael Di Cesare, former co-founder and chief operating officer, was appointed interim chief executive officer and vice-chairman effective immediately, according to a company statement.</p> <p>Marchelletta entered a four-month lock-up agreement covering 21 million common shares and temporarily assigned voting rights to Di Cesare as trustee during the lock-up period. He will continue deferring executive compensation at zero interest to support company operations.</p> <p>The company eliminated approximately $15 million in debt and canceled about 140 million common http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html Fri, 23 Jan 2026 17:39:10 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html <p>Jack Nathan Medical Corp. (TSXV: JNH) announced Mike Marchelletta stepped down as chief executive officer to lead a potential investor syndicate evaluating strategic transactions involving the company.</p> <p>Michael Di Cesare, former co-founder and chief operating officer, was appointed interim chief executive officer and vice-chairman effective immediately, according to a company statement.</p> <p>Marchelletta entered a four-month lock-up agreement covering 21 million common shares and temporarily assigned voting rights to Di Cesare as trustee during the lock-up period. He will continue deferring executive compensation at zero interest to support company operations.</p> <p>The company eliminated approximately $15 million in debt and canceled about 140 million common http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html Fri, 23 Jan 2026 17:39:10 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html <p>Jack Nathan Medical Corp. (TSXV: JNH) announced Mike Marchelletta stepped down as chief executive officer to lead a potential investor syndicate evaluating strategic transactions involving the company.</p> <p>Michael Di Cesare, former co-founder and chief operating officer, was appointed interim chief executive officer and vice-chairman effective immediately, according to a company statement.</p> <p>Marchelletta entered a four-month lock-up agreement covering 21 million common shares and temporarily assigned voting rights to Di Cesare as trustee during the lock-up period. He will continue deferring executive compensation at zero interest to support company operations.</p> <p>The company eliminated approximately $15 million in debt and canceled about 140 million common http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html Fri, 23 Jan 2026 17:39:10 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html <p>Jack Nathan Medical Corp. (TSXV: JNH) announced Mike Marchelletta stepped down as chief executive officer to lead a potential investor syndicate evaluating strategic transactions involving the company.</p> <p>Michael Di Cesare, former co-founder and chief operating officer, was appointed interim chief executive officer and vice-chairman effective immediately, according to a company statement.</p> <p>Marchelletta entered a four-month lock-up agreement covering 21 million common shares and temporarily assigned voting rights to Di Cesare as trustee during the lock-up period. He will continue deferring executive compensation at zero interest to support company operations.</p> <p>The company eliminated approximately $15 million in debt and canceled about 140 million common http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html Fri, 23 Jan 2026 17:39:10 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html <p>Jack Nathan Medical Corp. (TSXV: JNH) announced Mike Marchelletta stepped down as chief executive officer to lead a potential investor syndicate evaluating strategic transactions involving the company.</p> <p>Michael Di Cesare, former co-founder and chief operating officer, was appointed interim chief executive officer and vice-chairman effective immediately, according to a company statement.</p> <p>Marchelletta entered a four-month lock-up agreement covering 21 million common shares and temporarily assigned voting rights to Di Cesare as trustee during the lock-up period. He will continue deferring executive compensation at zero interest to support company operations.</p> <p>The company eliminated approximately $15 million in debt and canceled about 140 million common http://www.streetinsider.com/Management+Changes/Jack+Nathan+Medical+names+interim+CEO+amid+strategic+review/25888440.html Fri, 23 Jan 2026 17:39:10 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Press+Releases/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html <p> TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company’s next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. </p><p> Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transaction involving the Company. This alignment is intended to position the Company for long-term shareholder value creation by exploring innovative capital and partnership structures. There can be no assurance that any transaction will be completed, http://www.streetinsider.com/Business+Wire/Jack+Nathan+Medical+Corp.+Announces+CEO+Transition+and+Strategic+Investor+Alignment/25888437.html Fri, 23 Jan 2026 17:39:00 -0500 A.36078215 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Press+Releases/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077 http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html <p> TORONTO--(BUSINESS WIRE)-- <b>Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) </b>announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). </p><p> <b>Management Commentary</b> </p><p> Mike Marchelletta, Chief Executive Officer, commented: </p><p> “Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where http://www.streetinsider.com/Business+Wire/Jack+Nathan+Health+Announces+Its+Q2+Fiscal+2026+Financial+Results/25393483.html Mon, 29 Sep 2025 17:30:00 -0500 A.50208731 JNH JNHMF O.02555813 O.41101077